Announcements Trials

Browse Landscape

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

Specimen Handling 195 Magnetic Resonance Spectroscopy 154 pembrolizumab 152 Carboplatin 115 Biopsy 110 Cyclophosphamide 100 Cisplatin 88 Paclitaxel 80 Gemcitabine 72 Bevacizumab 70 fludarabine 61 Nivolumab 60 Radiotherapy 52 Fluorouracil 52 Capecitabine 49 Dexamethasone 48 Pemetrexed 46 Rituximab 44 Oxaliplatin 44 Docetaxel 44 Leucovorin 43 atezolizumab 42 Doxorubicin 42 venetoclax 39 durvalumab 39 Standard of Care 34 Prednisone 34 Temozolomide 33 Radiation 33 Cetuximab 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × ravulizumab × 30 days × Clear all

NCT06909253 2026-05-15

MG-ARCADIA

AstraZeneca

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡